NCT02226939View on ClinicalTrials.gov

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

November 30, 2002

Conditions
Liver CirrhosisHepatitis C, Chronic
Interventions
DRUG

BILN 2061 ZW

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY